A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment
Clinical trial NCT01610336 · COMPLETED
Trial details
- NCT number
- NCT01610336
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-05
- Primary completion
- 2016-06-10
- Enrollment
- 161
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.